跳至主要内容
临床试验/NL-OMON33909
NL-OMON33909招募中不适用

Optimization of electroconvulsive therapy (ECT) and continuation pharmacotherapy in major depressive disorder - Optimization of ECT

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Major depressive disorder (DSM-IV-TR)
  • Hamilton Rating Scale for Depression >= 18
  • ECT indication
  • If age >= 65 years, first depressive episode before age 65 and Mini Mental State Examination >= 24
  • At least 5 days free from medication before start doubble blind medication/ECT
  • Informed consent

排除标准

  • Alcohol- or drug dependence last 3 months
  • Serious neurologic illness
  • Endocrinologic illness affecting HPA-axis
  • Use of anti-epileptic medication
  • Bipolar disorder, schizoaffective disorder, schizophrenia
  • Contra-indication for nortriptyline
  • Pregnancy or possibility for pregnancy and no adequate contraceptive measures

研究者

相似试验

Optimization of electroconvulsive therapy (ECT) and... | 临床试验